Clay Thorp, Director, 10% Owner at Clearside Biomedical, Inc. (CLSD), sold 89,970 shares at $6.77 ($595K) on 2017-03-16, disclosed to the SEC on 2017-03-17.
Open-market sale of $595k CLSD by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.47 | 47,000 | $304K | 51.1% |
| 2 | $6.77 | 21,485 | $145K | 24.4% |
| 3 | $6.77 | 21,485 | $145K | 24.4% |
| Total | $6.61 avg | 89,970 | $595K | 100% |
| Filing → |
| CLSD | BUY | 2022-12-21 | $14K | — | Filing → |
| VIGL | BUY | 2022-05-17 | $165K | — | Filing → |
| VIGL | BUY | 2022-03-28 | $22K | — | Filing → |